StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Pfizer (PFE) to Buy Arena Pharmaceuticals (ARNA) in a $6.7 Billion Deal, Pays a 100% Premium; Seen as the First of Many Acquisitions
December 13, 2021 6:41 AM
Pfizer (NYSE: PFE) shares are up 2% in pre-open Monday after the company announced a deal to buy Arena Pharmaceuticals ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
Hot M&A
Mergers and Acquisitions
Next Articles
Pfizer (PFE) Announces FDA Approval of XELJANZ for the Treatment of Active Ankylosing Spondylitis
December 14, 2021 4:08 PM
Pfizer-BioNTech's COVID-19 Vaccine Giving 70% Protection Against Omicron, South Africa's Private Health Insurer Says
December 14, 2021 4:51 AM
UBS Upgrades Pfizer (PFE) to Buy, Downgrades Merck (MRK) to Neutral
December 13, 2021 9:51 AM
Pfizer’s (PFE) $6.7B Arena Acquisition is Priced Reasonably, May Offer Additional Upside, Pfizer Making Good Use of Cash – Analyst
December 13, 2021 9:30 AM
Low Valuations to Drive Pharma M&A in 2022 - Analyst
December 13, 2021 8:50 AM
UPDATE: UBS Upgrades Pfizer (PFE) to Buy
December 13, 2021 3:53 AM
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Following Hemophilia A Gene Therapy
December 12, 2021 4:30 PM
Pfizer (PFE) PT Raised to $54 at Barclays
December 10, 2021 4:36 AM
